LA JOLLA, Calif. , Sept. 22, 2016 (GLOBE NEWSWIRE) -- MyDx, Inc. (OTCQB:MYDX), a rapidly growing chemical detection company and the makers of MyDx®, the first multi-use hand-held chemical analyzer for consumers, today announced that in response to the contaminated water crisis in the Tampa, Florida area, it is offering affected area residents free standalone single use AquaDx sensors to test the safety of their drinking water. Residents may call (800) 814-4550 and choose Option 4 to have an AquaDx sensor that reports a Pass or Fail within 6 minutes shipped immediately while supplies last.
A photo accompanying this release is available at
A massive sinkhole at a Mosaic Company fertilizer plant in Mulberry, Florida, has caused about 215 million gallons of toxic water to drain down into the Floridian aquifer system, according to ABC News affiliate WFTS. Mulberry is about 45 minutes east of Tampa, and the aquifer system supplies drinking water to millions of Florida residents, according to the St. Johns Water Management District's website.
Trust and Verify® What You Drink
Fortunately for Central Florida residents, MyDx last week announced it was launching its AquaDx Sensor that works interchangeably with the multi-use, hand-held MyDx Analyzer for the analysis of toxic chemicals in water. The AquaDx Application is a next-generation system that puts sophisticated water chemical testing and analysis technology, and comprehensive tracking and reporting, in the palm of consumers’ hands conveniently and affordably. MyDx’s AquaDx sensor was recently featured in CNN.
The MyDx team will now also be offering a standalone single use disposable sensor product line that reports a Pass/Fail to AquaDx customers without the more sophisticated detailed analysis, reporting, and tracking features offered by the digital analyzer.
Commenting on the Mulberry water contamination incident, Daniel R. Yazbeck, MyDx Chairman and CEO, said, “I am sure that various government regulators are doing the best they can to protect the safety of the water supply from contamination that was reported to have begun August 27. In the meantime, days and weeks are far too long to find out if the water your family is drinking is poisonous, or not.
“Fortunately, in parallel to building inventory for our upcoming AquaDx launch, today we have begun shipping our standalone Single Use AquaDx sensors to media and residents affected by the Florida water crisis.
“The simple three step standalone single use sensor is an exciting new product line for MyDx, as it allows us to more quickly and affordably fill the needs of millions of consumers looking to trust and verify the safety of their drinking water. While the media reports the contamination is still spreading, MyDx is especially gratified for the opportunity to provide affected residents with a primary screening tool for harmful toxins in their drinking water today.”
The Next Generation of Consumer-Grade Water Quality Testing
The AquaDx application offers three different one-time disposable sensors, for:
MyDx will be shipping the AquaDx sensors that provides its users with a Pass or Fail result based on the presence of neurotoxic chemicals in water at concentrations that exceed the US Military Exposure Guideline (MEG) for safety of drinking water (assuming 7-14 day exposure, 15L/day consumption, 70kg person) and are below the estimated Human Lethal Consumption (HLC) guideline. This test covers key organophosphate/carbamate pesticides and toxic heavy metals. For more info about AquaDx, visit: https://www.cdxlife.com/aqua-sensor/.
About MyDx, Inc.
MyDx, Inc. (OTCQB: MYDX) is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust & Verify® what they put into their minds and bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user’s hand. The multi-use MyDx analyzer leverages over a decade of established technology to measure chemicals of interest. It owns a substantial and growing intellectual property portfolio of patents covering its technology. With its CannaDx™ sensor commercialized, it has three other sensors being developed in its lab that are compatible with the MyDx Analyzer and App that will empower consumers to test the chemical composition of everything they eat, drink and inhale. For more information, please visit www.cdxlife.com.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at http://ir.cdxlife.com/all-sec-filings or www.sec.gov.
This photo is also available at Newscom, www.newscom.com, and via AP Photo Express.GlobeNewswire
Last updated on: 25/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.